Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung Medical College and Chang Gung University, Taoyuan, Taiwan.
Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Stem Cell Res Ther. 2019 Aug 28;10(1):275. doi: 10.1186/s13287-019-1383-x.
Hypertrophic scars (HSs) are formed via an aberrant response to the wound healing process. HSs can be cosmetic or can result in functional problems. Prolonged proliferation and remodeling phases disrupt wound healing, leading to excessive collagen production and HS formation. However, there are currently no satisfactory drugs to prevent HS formation. Mesenchymal stem cell (MSC) conditioned medium (CM) has therapeutic effects on wound healing and preventing HS formation. Bone marrow concentrate (BMC) contains various growth factors and cytokines that are crucial for regeneration and has been applied in the clinical setting. In this study, we evaluated the effects of BMC-induced MSC CM on HS formation in a rabbit ear model.
We established a rabbit ear wound model by generating full-thickness wounds in the ears of rabbits (n = 12) and treated wounds with MSC CM, BMC CM, or BMC-induced MSC CM. Dermal fibroblasts from human hypertrophic scar were stimulated with transforming growth factor beta 1 (TGF-β1) for 24 h and cultured in each culture medium for 72 h. We measured the hypertrophic scar (HS) formation during the skin regeneration by measuring the expression of several remodeling molecules and the effect of these conditioned media on active human HS fibroblasts.
Our results showed that BMC-induced MSC CM had greater antifibrotic effects than MSC CM and BMC CM significantly attenuated HS formation in rabbits. BMC-induced MSC CM accelerated wound re-epithelization by increasing cell proliferation. Additionally, BMC-induced MSC CM also inhibited fibrosis by decreasing profibrotic gene and protein expression, promoting extracellular matrix turnover, inhibiting fibroblast contraction, and reversing myofibroblast activation.
BMC-induced MSC CM modulated the proliferation and remodeling phases of wound healing, representing a potential wound healing agent and approach for preventing HS formation.
增生性瘢痕(HSs)是通过对伤口愈合过程的异常反应形成的。HSs 可能会影响美观,也可能导致功能问题。延长的增殖和重塑阶段会破坏伤口愈合,导致过度的胶原蛋白产生和 HS 形成。然而,目前没有令人满意的药物可以预防 HS 的形成。间充质干细胞(MSC)条件培养基(CM)对伤口愈合和预防 HS 形成具有治疗作用。骨髓浓缩物(BMC)含有各种生长因子和细胞因子,对再生至关重要,并已在临床环境中应用。在本研究中,我们评估了 BMC 诱导的 MSC CM 对兔耳模型中 HS 形成的影响。
我们通过在兔耳上产生全层伤口来建立兔耳伤口模型(n=12),并用 MSC CM、BMC CM 或 BMC 诱导的 MSC CM 处理伤口。将人增生性瘢痕的真皮成纤维细胞用转化生长因子-β1(TGF-β1)刺激 24 小时,然后在每种培养基中培养 72 小时。我们通过测量几种重塑分子的表达来测量皮肤再生过程中的 HS 形成,并测量这些条件培养基对活性人 HS 成纤维细胞的影响。
我们的结果表明,BMC 诱导的 MSC CM 比 MSC CM 具有更强的抗纤维化作用,并且 BMC CM 显著减轻了兔的 HS 形成。BMC 诱导的 MSC CM 通过增加细胞增殖来加速伤口再上皮化。此外,BMC 诱导的 MSC CM 还通过降低促纤维化基因和蛋白表达、促进细胞外基质周转、抑制成纤维细胞收缩和逆转肌成纤维细胞激活来抑制纤维化。
BMC 诱导的 MSC CM 调节了伤口愈合的增殖和重塑阶段,代表了一种有潜力的伤口愈合剂和预防 HS 形成的方法。